Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen

Transcriptase Inhibitor ◽

Inhibitor Resistance ◽

Immune Reconstitution Is Comparable in Antiretroviral‐Naive Subjects after 1 Year of Successful Therapy with a Nucleoside Reverse‐Transcriptase Inhibitor– or Protease Inhibitor–Containing Antiretroviral Regimen

The Journal of Infectious Diseases ◽

10.1086/379041 ◽

2003 ◽

Vol 188 (10) ◽

pp. 1444-1454 ◽

Cited By ~ 24

Author(s):

Alan L. Landay ◽

John Spritzler ◽

Harold Kessler ◽

Donna Mildvan ◽

Minya Pu ◽

...

Keyword(s):

Protease Inhibitor ◽

Reverse Transcriptase ◽

Immune Reconstitution ◽

Transcriptase Inhibitor ◽

Successful Therapy ◽

Short Communication: Dolutegravir-Based Regimens Are Active in Integrase Strand Transfer Inhibitor–Naive Patients with Nucleoside Reverse Transcriptase Inhibitor Resistance

AIDS Research and Human Retroviruses ◽

10.1089/aid.2017.0184 ◽

2018 ◽

Vol 34 (4) ◽

pp. 343-346 ◽

Cited By ~ 14

Author(s):

James Demarest ◽

Mark Underwood ◽

Marty St. Clair ◽

David Dorey ◽

Dannae Brown ◽

...

Keyword(s):

Reverse Transcriptase ◽

Integrase Strand Transfer Inhibitor

Short Communication ◽

Transcriptase Inhibitor ◽

Strand Transfer ◽

Transfer Inhibitor ◽

Inhibitor Resistance ◽

Reverse Transcriptase Inhibitor ◽

Nucleoside reverse transcriptase inhibitor resistance mutations in subtype F1 strains isolated from heavily treated adolescents in Romania

International Journal of Infectious Diseases ◽

10.1016/j.ijid.2008.03.032 ◽

2009 ◽

Vol 13 (1) ◽

pp. 81-89 ◽

Cited By ~ 4

Author(s):

Simona Paraschiv ◽

Dan Otelea ◽

Cristian Baicus ◽

Mihaela Tinischi ◽

Marieta Costache ◽

...

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Resistance Mutations ◽

Inhibitor Resistance ◽

Phenotypic impact of HIV reverse transcriptase M184I/V mutations in combination with single thymidine analog mutations on nucleoside reverse transcriptase inhibitor resistance

AIDS ◽

10.1097/01.aids.0000131355.44834.e4 ◽

2004 ◽

Vol 18 (12) ◽

pp. 1691-1696 ◽

Cited By ~ 29

Author(s):

Lisa Ross ◽

Neil Parkin ◽

Colombe Chappey ◽

Robin Fisher ◽

Marty St Clair ◽

...

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Hiv Reverse Transcriptase ◽

Thymidine Analog ◽

Inhibitor Resistance ◽

Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial

The Lancet ◽

10.1016/s0140-6736(06)69074-0 ◽

2006 ◽

Vol 368 (9532) ◽

pp. 287-298 ◽

Cited By ~ 60

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Randomised Trial ◽

Transcriptase Inhibitor ◽

Open Label ◽

Malaria in HIV-Infected Children Receiving HIV Protease-Inhibitor- Compared with Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy, IMPAACT P1068s, Substudy to P1060

PLoS ONE ◽

10.1371/journal.pone.0165140 ◽

2016 ◽

Vol 11 (12) ◽

pp. e0165140 ◽

Cited By ~ 8

Author(s):

Charlotte V. Hobbs ◽

Erin E. Gabriel ◽

Portia Kamthunzi ◽

Gerald Tegha ◽

Jean Tauzie ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Hiv Protease ◽

Hiv Protease Inhibitor ◽

The choice between a ritonavir-boosted protease inhibitor- and a non-nucleoside reverse transcriptase inhibitor-based regimen for initiation of antiretroviral treatment – results from an observational study in Germany

Journal of Pharmaceutical Policy and Practice ◽

10.1186/s40545-016-0092-4 ◽

2016 ◽

Vol 9 (1) ◽

Cited By ~ 1

Author(s):

Jörg Mahlich ◽

Mona Groß ◽

Alexander Kuhlmann ◽

Johannes Bogner ◽

Hans Heiken ◽

...

Keyword(s):

Observational Study ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Antiretroviral Treatment ◽

Transcriptase Inhibitor ◽

Treatment Results ◽

Second-line protease inhibitor-based highly active antiretroviral therapy after failing non-nucleoside reverse transcriptase inhibitor-based regimens in Asian HIV-infected children

Antiviral Therapy ◽

10.3851/imp2494 ◽

2013 ◽

Vol 18 (4) ◽

pp. 591-598 ◽

Cited By ~ 8

Author(s):

Torsak Bunupuradah ◽

◽

Thanyawee Puthanakit ◽

Paul Fahey ◽

Azar Kariminia ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Highly Active Antiretroviral Therapy ◽

Transcriptase Inhibitor ◽

Second Line ◽

Highly Active ◽

An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma

Journal of Chromatography B ◽

10.1016/j.jchromb.2006.10.022 ◽

2007 ◽

Vol 848 (2) ◽

pp. 369-373 ◽

Cited By ~ 32

Author(s):

Dennis R. Weller ◽

Richard C. Brundage ◽

Henry H. Balfour ◽

Heather E. Vezina

Keyword(s):

Liquid Chromatography ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Human Plasma ◽

Transcriptase Inhibitor ◽

Chromatography Method ◽

Liquid Chromatography Method ◽

Etravirine: clinical review of a treatment option for HIV type-1-infected patients with non-nucleoside reverse transcriptase inhibitor resistance

Antiviral Therapy ◽

10.3851/imp1651 ◽

2010 ◽

Vol 15 (6) ◽

pp. 803-816 ◽

Cited By ~ 8

Author(s):

William J Towner ◽

Isabel Cassetti ◽

Pere Domingo ◽

Steven Nijs ◽

Thomas N Kakuda ◽

...

Keyword(s):

Reverse Transcriptase ◽

Clinical Review ◽

Treatment Option ◽

Transcriptase Inhibitor ◽

Hiv Type 1 ◽

Inhibitor Resistance ◽